Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population
In the POINT trial population, prior treatment with statin was marginally associated with decreased odds of early recurrence of stroke. However initiating statin treatment had no detectable effect in reducing risk of early stroke recurrence. The POINT trial provides no evidence for an immediate protective effect of statin initiation against early stroke recurrence.
Authors
- Shyam Prabhakaran (ORCID: https://orcid.org/0000-0003-3018-144X)
- James R. Brorson (ORCID: https://orcid.org/0000-0003-4137-2444)
- Elham Azizi
Institutions
- University of Chicago (US)
Publication Details
- Journal
- Journal of Stroke and Cerebrovascular Diseases
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108349
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke